Skip to content

ADPT

Adaptive Biotechnologies Corporation

Stock

$28.35+0.98 (+3.58%)Close Oct 2, 2026

Free cash flow, 2025
−$49M

Free cash flow

Free cash flow by fiscal year

PeriodFree cash flowYoY
2025−$49M—
2024−$99M—
2023−$167M—
2022−$200M—
2021−$254M—
2020−$168M—
2019$194M—
2018−$39M—
2017−$37M—